Redona Therapeutics, Inc.
Watertown, US · 2 known investors
Find your way into Redona Therapeutics, Inc.
Founders & leadership
Board
MS
Michal SilverbergBoard director
KS
LE
HR
Henrijette RichterBoard director
CB
Christine BrennanBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$66.8M disclosed across 2 rounds · 2018–2023
▶$6MraisedJul 2023 · 8 investors · BiotechnologyRule 506(b)
▶$6MraisedJul 2023 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michal SilverbergDirector
- Kazumi ShiosakiExecutive Officer, Director
- Luke EvninDirector
- Henrijette RichterDirector
- Christine BrennanDirector
- Offering amount
- $11.9M
- Amount sold
- $6M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$60.8MraisedJul 2023 · 11 investors · BiotechnologyRule 506(b)
▶$60.8MraisedJul 2023 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kazumi ShiosakiExecutive Officer, Director
- Henrijette RichterDirector
- Michal SilverbergDirector
- Christine BrennanDirector
- Luke EvninDirector
- Offering amount
- $76.9M
- Amount sold
- $60.8M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Redona Therapeutics, Inc.'s investors?
- Redona Therapeutics, Inc.'s investors include Astellas Venture Management LLC, MPM BioImpact.
- How much funding has Redona Therapeutics, Inc. raised?
- Redona Therapeutics, Inc. has disclosed $66.8M raised across 2 rounds.
- Where is Redona Therapeutics, Inc. headquartered?
- Redona Therapeutics, Inc. is headquartered in Watertown, US.